Home

|

EVMPD

|

Solution

 Pharma eReport Blog

Date: 21st March 2012, by: Nicky
Tags: EVMPD, XEVMPD, Centrality, software

EVMPD software provider Pharma eReport announces full general availability of Centrality XEVMPD compliance solution

Centrality software is fully compliant with March 2012 EMA specification updates and available now to pharmaceutical Marketing Authorisation Holders

 

Cambridge, UK, March 21 2012 - Pharma eReport, a software and services company that delivers a comprehensive EVMPD compliance solution for pharmaceutical regulatory professionals, today announces that its Centrality software suite is now in full general availability, incorporating the latest specification changes from the European Medicines Agency (EMA) issued on 5th March 2012. The software has been fully tested to compliantly generate valid, syntactically-correct XML data. Prospective customers can sign up and register for the software online now.


Pharma eReport – a subsidiary of ELC Group, the pan-European pharmaceutical regulatory affairs organisation – offers a full service solution to help Marketing Authorisation Holders (MAHs) meet the July 2nd 2012 deadline for mandatory EudraVigilance Medicinal Product Dictionary (EVMPD/XEVMPD) data submissions. Pharma eReport’s flagship Centrality software suite and specialist EVMPD services – delivered by a Key Support Services team of qualified chemists – provide a comprehensive, quality-assured EVMPD compliance solution that is available to customers now.

Pharma eReport’s Centrality software allows MAHs to easily convert existing medicinal product information into an XML Schema Definition (XSD)-compliant format, and seamlessly upload the required data as a EudraVigilance Product Report Message (EVPRM) using an approved submission mechanism. All software database elements as well as the XML output are directly driven from officially mandated EMA schema, and subject to stringent testing and QA procedures. The software is secure, easy to use and custom-engineered for flexible implementation, including development support for bespoke interfaces to provide full harmonisation with customers’ existing systems. Centrality allows the import and export of XML and CSV files, enabling total ease of integration with all existing enterprise and pharmaceutical regulatory software platforms and product life cycle management systems.

The Centrality software is offered via a transparent pricing model and with fully flexible deployment options. The Centrality platform is available as a secure, on-demand cloud-based application (Software-as-a-service) accessed via a standard web browser, or it can be installed as a standalone software application. For customers who wish to have all their data in-house, Centrality can be installed on a company intranet, so that the data is held on-site and authorised users can access it securely via the company system. The Centrality software solution is completely independent – no other software needs to be installed – and offers full support for both Windows and Linux.

Pharma eReport also provides a full range of Key Support and consulting service, including data collation, organisation and mapping capabilities, to help customers meet any challenge related to EVMPD implementation and ensure timely compliance with the EMA mandate.

Commenting on today’s announcement, Marco Rubinstein, CEO of Pharma eReport said: "We are delighted to be launching our Centrality software into full general availability today. Now is the critical time period for Marketing Authorisation Holders to select a software partner to help them meet the July 2012 EVMPD compliance deadline and we’ve worked hard to ensure that our Centrality solution is easy-to-use, fully compliant, secure and future-proof, offering the highest quality assurance and the best solution possible for our customers.” He continued: “The schema-derived nature of our platform means that any EMA specification changes – and, indeed, any intermediate schemes ahead of the planned ISO IDMP (Identification of Medicinal Products) standard – can be quickly and seamlessly incorporated into our platform. We’ve designed Centrality from the ground up to provide a total solution for managing ongoing, database-wide pharmacovigilance updates and ensuring continuing EMA regulatory compliance. We’re looking forward to helping our customers meet the short-term EVMPD compliance challenge and continuing to support them in a long-term, successful partnership.”

To sign-up online and become a registered user of Pharma eReport’s Centrality software, please visit: http://www.pharmaereport.com

---ends---

Press contacts
Nicky Denovan
Pharma eReport
nicky [at] pharmaereport [dot] com
Phone: +44 (0) 7747 017654 begin_of_the_skype_highlighting +44 (0) 7747 017654 end_of_the_skype_highlighting


About Pharma eReport (http://www.pharmaereport.com)
Cambridge, UK-based Pharma eReport provides intuitive electronic product data management and reporting software for pharmaceutical regulatory professionals.

With its flagship Centrality software suite and supporting specialist EVMPD services – delivered by a Key Support Services team of qualified chemists – Pharma eReport provides a comprehensive EVMPD solution, including complete outsourced data collation, organisation and mapping capabilities. The Centrality software is available as an on-demand software-as-a-service (SaaS)/cloud-based solution – accessed via a standard web browser – or it can be installed as a standalone software application at a client site.

Pharma eReport is co-founded by the management of ELC Group – a leading global services company with recognised expertise in regulatory affairs and Marketing Authorisation management – plus former executives from electronic design automation software company Synopsys, Inc. Pharma eReport harnesses the unparalleled industry knowledge of its regulatory expert founders and combines this with a world-class software development team to deliver a total solution for EVMPD compliance and beyond.

Blog Posts

15th September 2014, by: Nicky
Tags: XEVMPD, EMA
Pharma eReport delivers V5-compliant solution to help MAHs meet December 31st XEVMPD resubmission deadline

11th September 2014, by: Nicky
Tags: XEVMPD, EMA
Are you ready for the December 31st XEVMPD re-submission deadline?

3rd September 2012, by: Nicky
Tags: IRISS, ISO IDMP, EMA, DIA
IRISS IDMP Topic Group Leader Andrew Marr to present work of group at DIA Conference

24th June 2012, by: Nicky
Tags: EVMPD, XEVMPD, EMA
EMA updates eSubmission Gateway Q&A

12th June 2012, by: Nicky
Tags: EVMPD, XEVMPD, Centrality
XEVMPD software provider Pharma eReport launches Excel Data Import Service

30th May 2012, by: Nicky
Tags: EVMPD, XEVMPD, EMA, EudraVigilance
Response requested by 30 May 2012: EMA Options Paper

18th May 2012, by: Nicky
Tags: EVMPD, XEVMPD, EMA, EudraVigilance
XEVMPD e-Learning Course now online

4th May 2012, by: Nicky
Tags: EVMPD, XEVMPD, EMA, EudraVigilance
April 2012 EMA controlled vocabulary update

1st May 2012, by: Nicky
Tags: EVMPD, XEVMPD, EMA, EudraVigilance
EMA to host IDMP Information Day in London on May 8th

23rd April 2012, by: Nicky
Tags: EVMPD, XEVMPD, EMA, EudraVigilance
EudraVigilance XEVMPD e-learning course coming very soon

12th April 2012, by: Nicky
Tags: EVMPD, XEVMPD, ISO IDMP
Report: first meeting of IRISS IDMP Topic Group

21st March 2012, by: Nicky
Tags: EVMPD, XEVMPD, Centrality, software
EVMPD software provider Pharma eReport announces full general availability of Centrality XEVMPD compliance solution

14th March 2012, by: Nicky
Tags: EVMPD, XEVMPD, Centrality, software
Seven reasons to invest in an EVPRM system

13th March 2012, by: Nicky
Tags: EVMPD, XEVMPD
New: EVMPD spreadsheet for data entry freely available on our website

6th March 2012, by: Nicky
Tags: EVMPD, XEVMPD, EMA
Updated EVMPD guidance from EMA

21st February 2012, by: Nicky
Tags: EVMPD, XEVMPD, Centrality, Pharma eReport
We've launched!

20th February 2012, by: Nicky
Tags: EVMPD, XEVMPD, report
Call for participation: IRISS Forum topic group on Identification of Medicinal Products (including XEVMPD)

2nd February 2012, by: Lloyd
Tags: EMA
SSI to be optional

2nd February 2012, by: Nicky
Tags: EVMPD, XEVMPD, report
End of year EVMPD report from Marr Consultancy

31st January 2012, by: Nicky
Tags: EVMPD, XEVMPD, Article 57, blog, Pharma eReport
Welcome to our blog!